Ranking The XRP, Dogecoin, Solana, Litecoin ETF Approval Chances: One Altcoin Has A 90% Chance, Bloomberg Analyst Says

Benzinga
11 Feb

Spot altcoin ETFs stand a good chance of being confirmed in 2025, according to Bloomberg ETF analysts.

What Happened: Senior Bloomberg ETF analyst Eric Balchunas on Monday stated that Litecoin LTC/USD has the highest ETF approval odds at 90%.

Dogecoin DOGE/USD follows with 75%, Solana SOL/USD stands at 70% and an XRP XRP/USD ETF has a 60% chance of being approved, according to Balchunas.

The odds apply only to 1933 Act spot ETF filings like the iShares Bitcoin Trust ETF IBIT, but futures or 40 Act Cayman-structured ETFs could also get approval.

Notably, most of these had odds of under 5% before the election.

James Seyffart added that the SEC's stance has shifted, making XRP and Dogecoin filings likely to be acknowledged this week.

He emphasized that under continued Democratic control, most altcoin ETF approvals—except Litecoin—would have remained unlikely.  

The SEC, with Commissioner Peirce's crypto task force, will work to clarify security vs. commodity classifications by the end of 2025.

Also Read: Cardano Outperforms Bitcoin, Ethereum With 11% Gains After Grayscale Applies For First Ever ADA Spot ETF In US

What's Next: Altcoin Buzz noted that the DEX volume of Solana peaked to $60 million, almost double of Ethereum, targeting a 4-month winning streak over the latter.

Pro-XRP lawyer Jeremy Hogan on X noted that while ETF approval could happen quickly, the S-1 registration process could take 8-12 months before full market launch.

Read Next:

  •  Spot XRP ETF Filings Hit The Deck: ‘Hard To Be Bearish Here,’ Trader Says
$XRPRipple
$2.461.30%
Overview
$DOGEDogecoin
$0.25841.16%
$LTCLitecoin
$126.595.38%
$SOLSolana
$199.36-0.57%
IBITiShares Bitcoin Trust
$55.10-0.51%

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10